Enovis Corporation (ENOV) News

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical...

Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting

Wilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical...

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

WILMINGTON, DE, Aug. 20, 2024 (GLOBE NEWSWIRE) --  Enovis™ (NYSE: ENOV), an innovation-driven medical...

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

Wilmington, DE, Aug. 19, 2024 (GLOBE NEWSWIRE) --  Enovis™ Corporation (NYSE: ENOV), an innovation-driven...

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Enovis Announces Second Quarter 2024 Results

Continued strong momentum with second-quarter sales growth of 23% on a reported basis and strong adjusted...

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Wilmington, DE, July 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 424B7 - Prospectus [Rule 424(b)(7)]